pharmadocs GmbH & Co. KG

What pharmadocs GmbH & Co. KG does

pharmadocs GmbH & Co. KG is a German pharmaceutical regulatory affairs services firm headquartered in Bad Staffelstein, Bavaria, founded in 2009 by Peggy Schorn, who remains Managing Director. The company serves pharmaceutical companies seeking marketing authorization for human medicinal products, delivering an integrated five-service portfolio — Drug Approval, eCTD Service, Regulatory Advice, Regulatory Writing & Artwork, and Maintenance — that spans the full regulatory lifecycle from strategy and dossier preparation through submission to ongoing lifecycle management. Its core technical work centers on electronic Common Technical Document (eCTD) format submissions, including baseline creation, reformatting of legacy dossiers, and management of authority correspondence across EU and non-EU markets, with platform dependencies on the Common European Submission Platform (CESP) portal and EudraVigilance/xEVMPD systems.

The firm operates as a B2B professional services business on a direct, quote-based engagement model with no public pricing. Revenue is generated through project-based consulting retainers and per-engagement fees for dossier preparation, regulatory strategy, and ongoing maintenance work including variations, renewals, and PSUR submissions. Customers are exclusively pharmaceutical companies, served primarily through direct enterprise engagement and supported by content marketing via the company website, a regulatory affairs news blog, downloadable brochures, and limited community engagement (sponsorship of Brose Bamberg and Kinderhilfe Eckental). Post-marketing pharmacovigilance is delivered through a longstanding partnership with medwiss-extern GmbH & Co. KG, enabling pharmadocs to offer a full safety-monitoring capability without building it in-house.

The company is a founder-owned GmbH & Co. KG (limited partnership) with no external institutional investors, parent company, or subsidiaries, and is privately held. It holds ISO 9001 quality management certification and employs 15+ staff. Operating geographies span Europe and selective non-EU markets for marketing authorization work, with the German headquarters serving as the sole physical location. No funding rounds, acquisitions, or leadership changes outside the founder's continuous tenure have been disclosed.

Name

pharmadocs GmbH & Co. KG

Legal name

pharmadocs GmbH & Co. KG

Website

https://pharmadocs.de

Company type

Private

Founded year

2009

Operating status

Operating

Short description

pharmadocs GmbH & Co. KG is a German pharmaceutical regulatory affairs consultancy that prepares, submits, and maintains marketing authorization dossiers (eCTD) for human medicinal products on behalf of pharmaceutical companies across EU and non-EU markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Affairs Services

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH)

akta.pro secondary industry

Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Drug regulatory affairs
• ECTD submission services
• Marketing authorization consulting
• Pharmaceutical regulatory writing
• Medicinal product lifecycle management

Headquarters

HQ city

Bad Staffelstein

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Regulatory Affairs Services: Professional services revenue from pharmaceutical regulatory affairs consulting and documentation services. Services include drug approval, eCTD service, regulatory advice, regulatory writing and artwork, and maintenance - spanning from initial planning through submission to complete life cycle management.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

pharmadocs is an international B2B service provider for the pharmaceutical industry specializing in drug regulatory affairs and marketing authorization of human medicinal products. It delivers five integrated services across the full product lifecycle: Drug Approval strategy and dossier submission, eCTD Service for electronic dossier preparation and lifecycle management, Regulatory Advice/consulting, Regulatory Writing and Artwork (compliant labeling/SmPC/PIL/CCDS in English and German), and ongoing Maintenance including variations, renewals, PSURs, and EudraVigilance.

Product overview

pharmadocs GmbH & Co. KG offers a comprehensive suite of five integrated Drug Regulatory Affairs services for the pharmaceutical industry, covering the complete drug lifecycle from initial approval through post-market maintenance. The core portfolio consists of Drug Approval (Arzneimittelzulassung), eCTD Service, Regulatory Advice, Regulatory Writing und Artwork, and Maintenance. These services work together as an interconnected system: Drug Approval handles the initial authorization process, eCTD Service manages electronic document formatting and submission, Regulatory Advice provides strategic consulting, Regulatory Writing und Artwork creates compliant documentation, and Maintenance ensures ongoing regulatory compliance throughout the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Approval (Arzneimittelzulassung) Core service managing the complete drug approval process for human medicinal products, including strategy development, planning of approval procedures (MRP, DCP, CP), authority correspondence, and submission of registration dossiers covering Modules 1-5 of the Common Technical Document. Intended for pharmaceutical companies seeking marketing authorization.
• eCTD Service Electronic Common Technical Document service that prepares, validates, and submits registration dossiers in eCTD format, including reformatting existing dossiers to eCTD, creating eCTD baselines, and maintaining lifecycle management of submissions. Delivered for pharmaceutical companies requiring electronic submission compliance.
• Regulatory Advice (Regulatorische Beratung) Consulting service developing regulatory strategies, evaluating internal and external processes, creating SOPs, conducting product classification, cost-benefit analysis, due diligence, and advising on regulatory matters with drug authorities. Targeted at pharmaceutical companies navigating regulatory decision-making.
• Regulatory Writing und Artwork Creation and revision of legally compliant labeling, instructions for use, and specialist information in English and German; artwork review and release; and creation of Company Core Data Sheets (CCDS). Designed for pharmaceutical companies requiring compliant regulatory texts and packaging artwork.
• Maintenance Ongoing regulatory maintenance services covering dossier evaluation and updating, CMC compliance checks, variations and renewals planning and submission, Periodic Safety Update Reports (PSUR), and EudraVigilance deadline management. Intended for pharmaceutical companies needing to maintain marketing authorizations throughout the product lifecycle.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• medwiss-extern GmbH & Co. KGcoreStrategic or Co-development PartnerLongstanding business partnership for pharmacovigilance services. pharmadocs specializes in drug regulatory affairs and marketing authorization while relying on medwiss-extern's expertise for post-marketing pharmacovigilance services. The partnership enables pharmadocs to offer comprehensive service portfolio including safety monitoring and risk minimization measures required after drug approval.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PharmaLex (Capgemini Invent): One of the largest dedicated regulatory affairs and pharmacovigilance consultancies serving the pharmaceutical industry globally. Most directly comparable to pharmadocs in service scope (RA strategy, eCTD, submissions, maintenance); much larger scale and now backed by Capgemini.
• ProPharma Group: Regulatory compliance, pharmacovigilance, and quality/compliance consulting for pharma and biotech. Comparable service mix (regulatory strategy, submissions, GxP compliance) and similar mid-market client focus to pharmadocs.
• Diamond Pharma Services: Specialist regulatory affairs and pharmacovigilance consultancy supporting pharma companies across EU and global markets. Closely comparable niche focus and service portfolio to pharmadocs, including MA submissions and lifecycle maintenance.
• Veristat: Regulatory consulting and clinical research organization focused on product approval and post-approval activities. Comparable in regulatory strategy, submissions, and lifecycle management, though with a heavier clinical research tilt than pharmadocs.
• MakroCare: Global regulatory affairs and pharmacovigilance services provider for pharma and biotech. Comparable in regulatory submissions, eCTD, and lifecycle management, particularly for clients in EU and emerging markets.

Broad incumbents

• Huron Consulting Group (Life Sciences): Large management consultancy with a life sciences practice covering regulatory, compliance, and operational consulting for pharma. Comparable services but within a broader portfolio and at much larger scale than pharmadocs.
• IQVIA: Largest global CRO with deep regulatory affairs capabilities including submissions, eCTD, and lifecycle management. Comparable services as part of a much broader clinical and commercial offering; competes primarily for larger enterprise clients.
• ICON plc: Major global CRO with regulatory affairs and pharmacovigilance service lines. Comparable functional capabilities but at significantly larger scale and broader scope than pharmadocs' boutique offering.
• Parexel International: Global CRO with comprehensive regulatory consulting, submissions, and pharmacovigilance capabilities. Comparable service categories but operates at significantly larger scale across multiple geographies, competing for the same pharma clients.
• Medpace: Mid-to-large CRO with regulatory affairs support embedded within its clinical research services. Comparable regulatory offerings but as part of a broader clinical-focused portfolio, generally serving larger sponsors than pharmadocs targets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about pharmadocs GmbH & Co. KG